OT mobile menu

Search form



P Values and 'Data Dredging' in Clinical Research

We spoke with Dr. Garrett-Mayer about the significance of P values in clinical research. Image © mstanley/Shutterstock.com 

Recent Content

Penn State College of Medicine researchers have discovered a new class of drugs that may keep a deadly form of skin cancer from becoming resistant to treatment.

A 43-year-old woman presents with a lesion in the thyroid gland. After further assessment a biopsy is performed. What is your diagnosis?

A new population-based study is suggesting that there are significant racial disparities in gene expression profiling testing in women with breast cancer.

We spoke with Dr. G. Larry Maxwell, Chair of the Department of Obstetrics and Gynecology at Inova Fairfax Hospital, about a potential new biomarker to help distinguish metastatic versus nonmetastatic disease in endometrial cancer.

Researchers at the NYU Langone Medical Center’s Perlmutter Cancer Center have discovered multiple somatic mutations and copy-number alterations in UCS tumors that offer expanded therapeutic options.

Scientists from Dana-Farber Cancer Institute found that a compound that can reverse the function of innate immune system cells—to fight tumors rather than encourage growth—caused breast tumors in mice to shrink and withdraw from distant metastases.

We spoke with Dr. Elizabeth Swisher about the ARIEL2 trial and the role of rucaparib in ovarian cancer.

By clicking Accept, you agree to become a member of the UBM Medica Community.